(Q34555592)

English

Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

0 references

Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis (English)

1 reference

Europe PubMed Central

3 August 2017

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

0 references

stem cell transplantation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

3 August 2017

author name string

Masamitsu Yanada

1

1 reference

Europe PubMed Central

3 August 2017

Nobuhiko Emi

3

1 reference

Europe PubMed Central

3 August 2017

Tomoki Naoe

4

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 April 2005

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

103

1 reference

Europe PubMed Central

3 August 2017

1652-1658

1 reference

Europe PubMed Central

3 August 2017

8

1 reference

Europe PubMed Central

3 August 2017

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

21 January 2018

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Grup

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--a statistician's view

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20945

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20945

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34555592&oldid=1981641373"